Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes [0.03%]
儿童和青少年1型糖尿病患者早期使用连续血糖监测：启动率及对血糖结果的影响
Elizabeth A Mann,Saketh Rompicherla,Brian Miyazaki et al.
Elizabeth A Mann et al.
Objective: Early initiation of continuous glucose monitor (CGM) after type 1 diabetes (T1D) diagnosis has been associated with lower hemoglobin A1C (HbA1c) in single-institution studies. This multicenter study evaluated t...
Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) [0.03%]
基于模型的参数在2型糖尿病中不同治疗效果对β细胞功能的影响：来自血糖降低方法在糖尿病中的比较有效性研究(GRADE)的结果
Kristina M Utzschneider,Mark Tripputi,Nicole M Butera et al.
Kristina M Utzschneider et al.
Objective: To evaluate how model-based parameters of β-cell function change with glucose-lowering treatment and associate with glycemic deterioration in adults with type 2 diabetes (T2D). ...
Development and Validation of the Patient-Level Chinese Diabetes Outcome Model on Long-term Complications in Type 2 Diabetes: An Application of the Hong Kong Diabetes Register [0.03%]
中国2型糖尿病患者长期并发症的糖尿病预后模型开发及验证——基于香港糖尿病监测档案的应用
Eric S H Lau,Andrea O Y Luk,Lee-Ling Lim et al.
Eric S H Lau et al.
Objective: Patient-level simulation models, mainly developed in Western populations, capture complex interactions between risk factors and complications to predict the long-term effectiveness and cost-effectiveness of nov...
Is There a Place for Inhaled Insulin in the Era of Automated Insulin Delivery? [0.03%]
在自动化胰岛素递送时代吸入式胰岛素有一席之地吗？
Zhengli Bai,Elaine Chow
Zhengli Bai
Can Preventive Drug Lists Make High-Deductible Health Plans Safer for People With Diabetes? [0.03%]
预防性药物列表能否使高免赔额健康计划更安全地服务于糖尿病患者？
Kaitlynn S Robinson-Ector,Rozalina G McCoy
Kaitlynn S Robinson-Ector
Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653-659 [0.03%]
Foss-Freitas等关于“胰高血糖素样肽1受体激动剂在家族性部分脂质代谢异常患者中疗效和安全性的回顾性研究”的评论回复糖尿病护理2024;47:653-659
Maria C Foss-Freitas,David T Broome,Elif A Oral
Maria C Foss-Freitas
Response to Comment on Nathan et al. Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial. Diabetes Care 2024;47:2155-2163 [0.03%]
对Nathan等人文章《不同种族群体的平均血糖水平与HbA1c之间的关系：GRADE随机试验的一个亚组研究》评论的回应。糖尿病护理2024;47:2155-2163
David M Nathan
David M Nathan
Response to Comment on Rhee et al. Genetic BMI and Diabetes: Unraveling the Complexities of Obesity and Metabolic Health [0.03%]
对Rhee等人的评论的回应：遗传性BMI与糖尿病：解开肥胖和代谢健康之间的复杂关系
Tae-Min Rhee,Soo Heon Kwak
Tae-Min Rhee
Response to Comments on Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024;47:1257-1275 [0.03%]
对《成人糖尿病高血糖危象的共识报告》评论的回复。糖尿病护理 2024;47:1257-1275
Guillermo E Umpierrez,Georgia M Davis,Nuha ElSayed et al.
Guillermo E Umpierrez et al.
Dorothy Crowfoot Hodgkin (1910-1994): X-ray Crystallography and the Intricacy of Molecular Maps [0.03%]
多萝西·克劳福特·霍奇金（1910-1994）：X射线晶体学和分子图的复杂性
Benjamin Page
Benjamin Page